Amber Feng, MD^1*, Taewoong Choi, MD², Jian Wu, MD, PhD^2*, Xiaobei Wang, PhD^2*, Tanya Bellavia, PA-C^2*, Daniel Schrum, PharmD^2*, Erin Eberwein, PharmD^2*, Sikai Cheng, BS^1*, Jonathan Huggins, MD^1*, Patrick Tam, MD^1*, Suzanne Kirby, MD, PhD², Cristina Gasparetto, MD^3*, Cristiana Costa Chase, DO², Gwynn D. Long, MD^3*, Krista Rowe-Nichols, RN^2* and Yubin Kang, MD³

¹Duke University Hospital, Durham, NC
²Division of Hematologic Malignancies and Cellular Therapy, Duke Cancer Institute, Durham, NC
³Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC

Noffar Bar, MD¹, Roberto Mina^2*, Anne K. Mylin^3*, Hisayuki Yokoyama^4*, Hila Magen^5*, Winfried Alsdorf^6*, Monique C. Minnema⁷, Leyla O. Shune, MD⁸, Iris Isufi, MD⁹, Simon J Harrison, MBBS, PhD^10,11,12, Urvi A. Shah, MD¹³, André De Champlain^14*, Katharine S. Gries^15*, Diana Chen^16*, Quanlin Li^17*, Tzu-Min Yeh^18*, Ana Slaughter^19*, Carolina Lonardi^20*, Nina Benachour^21*, Arnab Ghosh^22*, William Deraedt^23*, Martin Vogel^24*, Nikoletta Lendvai^25*, Nitin Patel^26*, Octavio Costa Filho^26*, Erika Florendo^26*, Lionel Karlin^27* and Katja C. Weisel, MD⁶

¹Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
²Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
³Department of Hematology, Rigshospitalet, Copenhagen, Denmark
⁴Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan
⁵Chaim Sheba Medical Center, Ramat-Gan, Sackler Faculty of Medicine, Tel Aviv University, Petach Tikva, ISR
⁶University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁷Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands
⁸Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas, Westwood, KS
⁹Division of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
¹⁰Royal Melbourne Hospital, Melbourne, Australia
¹¹Peter MacCallum Cancer Centre, Melbourne, Australia
¹²Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia
¹³Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY
¹⁴Janssen Global Services, LLC, Horsham, PA
¹⁵Janssen Research & Development, LLC, Raritan, NJ
¹⁶Janssen Research & Development, Shanghai, China
¹⁷Janssen Research & Development, Apex, NC
¹⁸Janssen Research and Development, Raritan, NJ
¹⁹Cilag GmbH International, Zug, Switzerland
²⁰Janssen, Buenos Aires, Argentina
²¹Janssen Research & Development, Beerse, Belgium
²²Janssen Research & Development, Raritan, NJ
²³Janssen Research and Development, Beerse, Belgium
²⁴Janssen Research & Development, Neuss, Germany
²⁵Oncology Clinical Development, Johnson and Johnson Innovative Medicine, Bridgewater, NJ
²⁶Legend Biotech USA Inc., Somerset, NJ
²⁷Centre Hospitalier Lyon Sud, Pierre-Bénite, France

Nico Gagelmann, MD^1*, Friedrich Stölzel^2*, Roland Fenk, MD, PhD^3*, Tobias A.W. Holderried, MD^4*, Fabian Mueller, MD^5*, Natalia Tovar, MD^6*, Aina Oliver-Caldés, MD, PhD^7*, Kristin Rathje^8*, Vladan Vucinic, MD^9*, Soraya Kharboutli, MD^5*, Ben-Niklas Bärmann^10,11*, Francis A. Ayuk, M.D.^12*, Uwe Platzbecker, MD¹³, Anca Maria Albici^14*, Natalie Schub^15*, Friederike Schmitz^16*, Cyrus Khandanpour¹⁷, Marcel Teichert^18*, Barbara Jeker^19*, Nicolaus Kroeger^12,20, Bastian von Tresckow²¹, Carlos Fernandez de Larrea, MD²², Thomas Pabst²³ and Maximilian Merz, MD¹³

¹Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany
²Division of Stem Cell Transplantation and Cellular Immunotherapies, University Hospital Schleswig-Holstein, Kiel, Germany
³Department of Haematology, Oncology, and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany
⁴Universitaetsklinikum Bonn (UKB), Bonn, Germany
⁵Department of Internal Medicine 5 - Hematology and Oncology, University Hospital of Erlangen, Erlangen, Germany
⁶Hospital Clinic de Barcelona, IDIBAPS., Barcelona, Spain
⁷Hospital Universitari Son Espases, IdISBa, Palma de Mallorca, ESP
⁸Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, AL, Germany
⁹Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig, Leipzig, Saxony, Germany
¹⁰DüSseldorf University Hospital, DüSseldorf, ERI
¹¹Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany
¹²Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
¹³Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
¹⁴Division of Stem Cell Transplantation and Cellular Immunotherapies, University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany
¹⁵Department of Internal Medicine II, Division of Stem Cell Transplantation and Immunotherapy, UKSH Campus, Kiel, Germany
¹⁶Department of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany
¹⁷University Cancer Center Schleswig-Holstein, Campus Luebeck, Luebeck, Germany
¹⁸Department of Hematology and Stem Cell Transplantation, Department of Hematology and Oncology, University Hospital Essen, Essen, Germany, Essen, Germany
¹⁹Department of Medical Oncology, Bern University Hospital, Bern, Switzerland
²⁰Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Hamburg, DEU
²¹Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany
²²Amyloidosis and Myeloma Unit, Hospital Clínic, Barcelona, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
²³Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland

Fnu Amisha, MD¹, Ziad Abuhelwa, MD, MPH¹, Wenyi Fan, MSPH^2*, Doris K. Hansen, MD^3*, Omar Castaneda, MD³, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP³, Hien Liu, MD³, Frederick Locke, MD⁴, Taiga Nishihori, MD⁴, Ariel Grajales-Cruz, MD⁵, Brandon Blue, MD⁵, Kenneth H. Shain, MD, PhD⁵, Melissa Alsina, MD⁴ and Rachid Baz, MD⁴

¹Department of Hematology and Oncology, USF Morsani/H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴Moffitt Cancer Center, Tampa, FL
⁵Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Rafael Fonseca, MD¹, Joris Diels^2*, Francesca Ghilotti^3*, João Mendes^4*, Teresa Hernando^5*, Seina Lee^4*, Jordan M. Schecter⁶, Nikoletta Lendvai^7*, Nitin Patel^8*, Ana Triguero^9*, Winfried Alsdorf^10* and Margherita Ursi^11*

¹Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
²Janssen Pharmaceutica NV, Beerse, Belgium
³Janssen-Cilag SpA, Milano, Italy
⁴Janssen Global Services, LLC, Raritan, NJ
⁵Janssen-Cilag, Madrid, Spain
⁶Janssen Research and Development, LLC, Raritan, NJ
⁷Oncology Clinical Development, Johnson and Johnson Innovative Medicine, Bridgewater, NJ
⁸Legend Biotech USA Inc., Somerset, NJ
⁹Hosp. Clinic I Provincial de Barcelona, Barcelona, Spain
¹⁰Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany
¹¹Istituto di Ematologia "Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy, Bologna, Italy

Hitomi Hosoya, MD, PhD¹, Alexandria Jensen^2*, Vanna Hovanky, MS^3*, Sylvester Homsy, MD⁴, Juancarlos E Cancilla^5*, Sunita Patil^5*, Vanessa E. Kennedy, MD¹, Sushma Bharadwaj, MD¹, Melody Smith, MD, MS⁶, Parveen Shiraz^7*, Matthew J. Frank, MD, PhD⁸, Saurabh Dahiya, MD, FACP^7*, Sally Arai, MD⁷, Wen-Kai Weng, MD, PhD¹, Lori Muffly, MD⁶, Bita Sahaf^7*, Crystal L. Mackall, MD⁹, David B. Miklos, MD, PhD¹, Lekha Mikkilineni, MD, MA¹⁰ and Surbhi Sidana, MD⁶

¹Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
²Quantitative Sciences Unit, Stanford University, Stanford, CA
³Stanford University, Stanford, CA
⁴Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Brooklyn, Lebanon
⁵Cancer Correlative Science Unit, Stanford University, Palo Alto, CA
⁶Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
⁷Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
⁸Stanford Cancer Institute, Center for Cancer Cell Therapy, Stanford University, Stanford, CA
⁹Department of Medicine, Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA
¹⁰Division of Blood and Marrow Transplant and Cellular Therapy, Stanford University, Palo Alto, CA

Johannes Waldschmidt, MD¹, David Fandrei, MSc^2*, Vladan Vucinic, MD^3*, Ralph Wäsch⁴, Axel Nogai, MD^5*, Winfried Alsdorf^6*, Annamaria Brioli, MD, PhD^7,8*, Evgenii Shumilov^9*, Fabian Mueller, MD¹⁰, Raphael Teipel, MD^11*, Nico Gagelmann, MD^12*, Monika Engelhardt, MD¹³, Jan Krönke, MD¹⁴, Julia Mersi, MD^1*, Michael Hudecek, MD, PhD^1*, Martin K. Kortüm^15*, Uwe Platzbecker, MD², Hermann Einsele, MD¹⁶, Max S. Topp^1*, Leo Rasche, MD^17,18* and Maximilian Merz, MD²

¹Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
²Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
³Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig, Leipzig, Saxony, Germany
⁴Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany
⁵Charité Medical University, Berlin, Germany
⁶University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁷Klinik für Innere Medizin C, Universitätsmedizin Greifswald, Greifswald, Germany
⁸Department of Hematology and Oncology, Medizinische Hochschule Hannover, Hannover, Germany
⁹Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
¹⁰Department of Internal Medicine 5 - Hematology and Oncology, University Hospital of Erlangen, Erlangen, Germany
¹¹Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
¹²Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany
¹³Department of Hematology, Oncology and Stem Cell Transplantation, Medical Centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
¹⁴Charité - Universitätsmedizin Berlin, Berlin, Germany
¹⁵Würzburg University Hospital, Wuerzburg, Germany
¹⁶Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
¹⁷Mildred-Scheel-Nachwuchszentrum, Wuerzburg, Germany
¹⁸Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany

Ahmad Iftikhar, MD^1*, Hiba Arshad Shahani, MBBS^2*, Mohammad Ebad Ur Rehman, MBBS^2*, Muhammad Sheraz Hameed, MBBS^3*, Syed Ali Raza Abidi, MBBS^4*, Fathima Shehnaz Ayoobkhan, MD⁵, Rana Uzair Ahmad, MBBS^6*, Afreen Quadri, MBBS^7*, Muhammad Suhaib^8*, Omar A Safdar^1*, Faiz Anwer, MD⁹ and Muhammad Husnain, M.D.¹

¹University of Arizona, Tucson, AZ
²Rawalpindi Medical University, Rawalpindi, Pakistan
³Rawalpindi Medical University, Rawalpindi, PAK
⁴D.G. Khan Medical College, Dera Ghazi Khan, Pakistan
⁵Trinity Health Oakland, Pontiac, MI
⁶King Edward Medical University, Lahore, Pakistan
⁷Dr. V. R.K. Women’s Medical College, Aziznagar, India
⁸Allama Iqbal Medical College, Lahore, Pakistan
⁹Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Alma Habib, MD^1,2, Nausheen Ahmed, MD^1,3, Abdullah Mohammad Khan, MD, MBBS^1,2, Darryl Chang, MD^1,4, Barry Paul, MD, MS^1,4, Hira Shaikh, MD^1,5, Christopher Strouse, MD^1,5, Emily Struble, DNP^1,5*, Andrew Vegel, MD^1,5*, James A Davis, PharmD^1,6*, Kimberly M Green, DO^1,6*, Hamza Sloan Hashmi, MD^6,7,8*, Zahra Mahmoudjafari, PharmD^1,9*, Muhammad Umair Mushtaq^1,9, Joseph P. McGuirk, DO¹⁰, Al-Ola Abdallah, MD^1,9, Shebli Atrash, MD, MS^1,4 and Reed Friend, MD^1,4

¹US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
²Division of Hematology, The Ohio State University, Columbus, OH
³University of Kansas Cancer Center, Kansas City, KS
⁴Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
⁵Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁶Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
⁷Myeloma Service, Department of Medicine, Memorial Sloan Kettering, Charleston, SC
⁸US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, NY
⁹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
¹⁰Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Ctr., Westwood, KS